cbdMD (YCBD) EBITDA (2016 - 2025)
Historic EBITDA for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to -$685816.0.
- cbdMD's EBITDA fell 11664.99% to -$685816.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year increase of 3477.15%. This contributed to the annual value of -$2.2 million for FY2025, which is 3477.16% up from last year.
- As of Q3 2025, cbdMD's EBITDA stood at -$685816.0, which was down 11664.99% from -$904686.0 recorded in Q2 2025.
- cbdMD's 5-year EBITDA high stood at -$86272.0 for Q4 2024, and its period low was -$33.1 million during Q2 2022.
- Over the past 5 years, cbdMD's median EBITDA value was -$1.8 million (recorded in 2023), while the average stood at -$6.5 million.
- In the last 5 years, cbdMD's EBITDA plummeted by 132874.11% in 2021 and then soared by 9791.97% in 2024.
- cbdMD's EBITDA (Quarter) stood at -$25.1 million in 2021, then surged by 83.91% to -$4.0 million in 2022, then surged by 73.66% to -$1.1 million in 2023, then soared by 91.91% to -$86272.0 in 2024, then plummeted by 694.95% to -$685816.0 in 2025.
- Its EBITDA stands at -$685816.0 for Q3 2025, versus -$904686.0 for Q2 2025 and -$485816.0 for Q1 2025.